Rosemary and its active compounds show genuine kidney-protective effects in laboratory and animal research, reducing markers of damage, inflammation, and scarring across dozens of preclinical studies. The catch is that none of this has been confirmed in human clinical trials. A 2025 review described rosemary as “a promising therapeutic agent for nephrotoxicity” while noting the evidence comes almost entirely from animal models and cell cultures, not from people taking rosemary supplements or eating rosemary-seasoned food.1Journal of Food Biochemistry. Rosemary: A Promising Therapeutic Agent in Alleviating Nephrotoxicity That gap between lab promise and bedside proof matters, but the preclinical picture is unusually consistent and worth understanding.
What Rosemary Does at the Cellular Level
The kidney-protective effects of rosemary trace back to a handful of compounds, with rosmarinic acid and carnosic acid drawing the most research attention. Both are polyphenols with strong antioxidant and anti-inflammatory activity. In kidney cells, they activate a defense system centered on a protein called Nrf2, which controls genes that neutralize harmful molecules. When rosmarinic acid was given to rats exposed to the pesticide chlorpyrifos, it boosted antioxidant defenses, reduced markers of cell death, and increased the activity of the Nrf2 pathway in their kidneys.2Life Sciences. Rosmarinic acid mitigates chlorpyrifos-induced oxidative stress, inflammation, and kidney injury in rats by modulating SIRT1 and Nrf2/HO-1 signaling
In a more recent study, rosmarinic acid enhanced the accumulation of Nrf2 in kidney cell nuclei by about two and a half times and roughly doubled the output of several protective enzymes downstream.3Biomedicine & Pharmacotherapy. Rosmarinic acid activates the Nrf2/HO-1 axis and suppresses NF-κB to protect against gentamicin-induced acute kidney injury Carnosic acid, the other major rosemary compound, works through a similar route. In mesangial cells bathed in high-glucose solutions meant to mimic diabetic conditions, carnosic acid restored the expression of protective genes that high sugar had suppressed.4Phytomedicine. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway At the same time, both compounds dial down a separate inflammatory pathway driven by a protein called NF-κB, which fuels tissue damage when it runs unchecked.
The practical upshot: rosemary compounds appear to turn up the kidney’s own protective machinery while turning down the signals that drive inflammation and cell death. This dual action is what makes them attractive candidates for kidney protection, at least on paper.
Protection Against Drug-Induced Kidney Damage
Some of the strongest animal evidence involves drugs known to harm the kidneys as a side effect. Cisplatin, a widely used chemotherapy agent, is infamous for causing kidney injury. When mice were given rosmarinic acid alongside cisplatin, it significantly reduced the spike in creatinine and blood urea nitrogen (two standard markers of kidney function), and it dampened the oxidative stress, inflammation, and cell death that cisplatin triggers in kidney tissue.5Food and Chemical Toxicology. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice
Gentamicin, an antibiotic that can cause acute kidney injury at high or prolonged doses, tells a similar story. In one rat study, animals receiving a high dose of rosemary extract alongside gentamicin maintained creatinine and urea levels within normal ranges, while the gentamicin-only group showed clear kidney dysfunction.6International Journal of Basic & Clinical Pharmacology. Renal biomarkers of Rosemarinus officinalis L. on gentamicine induced acute kidney injury in adult male albino rats A separate experiment using a chemical carcinogen and iron compound to induce acute kidney toxicity found that rosmarinic acid had the strongest antioxidant impact among the agents tested, including green tea extract and whole rosemary extract.7Sciendo / Interdisciplinary Toxicology. Nephroprotective effect of green tea, rosmarinic acid and rosemary on N-diethylnitrosamine initiated and ferric nitrilotriacetate promoted acute renal toxicity in Wistar rats
These findings are relevant because drug-induced kidney injury is a real clinical problem. It accounts for a meaningful share of acute kidney injury cases in hospital settings. If a plant compound could soften that blow without interfering with the drug’s intended action, that would be valuable. But this “if” remains unresolved: the animal models are encouraging, yet no one has run a controlled trial to see whether rosemary extract actually protects human kidneys during chemotherapy or antibiotic treatment.
Ischemia-Reperfusion Injury
Another scenario where kidneys suffer is ischemia-reperfusion injury, which occurs when blood flow to the kidney is temporarily cut off and then restored. This happens during certain surgeries, organ transplantation, and severe episodes of low blood pressure. Paradoxically, the flood of oxygen returning to starved tissue generates a burst of damaging molecules.
Rosmarinic acid has been tested in rat models of this type of injury. In one study, it reduced markers of oxidative damage such as malondialdehyde, suppressed the inflammatory signaling cascade involving TLR4, NF-κB, and TNF-α, and improved the histological appearance of kidney tissue.8PubMed. Rosmarinic acid: a promising agent for male rats’ renal protection against ischemia/reperfusion injury A separate experiment found that rosmarinic acid improved kidney recovery after ischemia-reperfusion by boosting antioxidant enzymes and nitric oxide while lowering lipid peroxidation.9Journal of Nephropharmacology. Rosmarinic acid ameliorates renal ischemia reperfusion damage in rats These two studies used different injury protocols and measurement endpoints, yet arrived at the same conclusion, which is a good sign for robustness, even though both are still limited to rats.
Kidney Scarring and Chronic Disease
Acute injury is one thing, but many people with kidney concerns are worried about gradual decline. Chronic kidney disease often progresses through fibrosis, where healthy kidney tissue is slowly replaced by scar tissue. Two studies have specifically looked at rosmarinic acid’s effect on kidney fibrosis, both using a surgical model in mice where one ureter is tied off to force scarring.
The first found that rosmarinic acid reduced the expression of several proteins involved in scar formation, including collagen I, fibronectin, and a growth factor (TGF-β1) that drives the process, while preserving a protein (E-cadherin) that keeps kidney cells from transforming into scar-producing cells.10PubMed. Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial-mesenchymal transition in vitro and in vivo The second zeroed in on an inflammasome pathway (NLRP3) that links chronic inflammation to fibrosis. Rosmarinic acid suppressed this pathway, and when combined with an NLRP3-specific inhibitor, the anti-fibrotic effect was even stronger.11International Immunopharmacology. Renoprotective effect of rosmarinic acid by inhibition of indoxyl sulfate-induced renal interstitial fibrosis via the NLRP3 inflammasome signaling
Fibrosis is the engine of progressive kidney failure, and current medicine has limited tools to slow it down. A compound that targets multiple fibrotic pathways at once is exactly what researchers want. The challenge, again, is getting from mouse kidneys to human ones.
Rosemary and Kidney Stones
Kidney stones are a distinct problem from kidney injury or chronic disease, but they overlap in the same organ and the same search queries. One study tested rosemary aqueous extract in rats given ethylene glycol to induce calcium oxalate stones. Histological examination showed no oxalate crystals in the kidneys of the treated group. The researchers attributed the effect partly to rosemary’s influence on serum phosphate, parathyroid hormone levels, and a protein called osteopontin that promotes crystal attachment in kidney tissue, and partly to the phenolic and flavonoid content of the extract.12Current Bioactive Compounds. Role of Rosmarinus officinalis Aqueous Extract in Relieving the Complications Associated with Ethylene Glycol-induced Urolithiasis in Male Rats
This is a single study and should be treated accordingly. Kidney stone prevention in humans depends on stone type, diet, hydration, and metabolic factors that a rat model cannot capture. Still, traditional use of rosemary tea as a kidney-cleansing drink has existed for centuries, and it is interesting that at least one controlled animal experiment found a plausible mechanism behind the folk practice.
Rosemary as a Mild Diuretic
Rosemary has a long reputation in herbal medicine as a diuretic, and there is animal evidence to back this up. Rats given a daily oral dose of rosemary aqueous extract showed significantly increased urine output starting around the fifth day of treatment, along with increased excretion of sodium, potassium, and chloride. Interestingly, the lower concentration tested (8%) was more effective than the higher one (16%) for both water and electrolyte excretion.13PubMed. Experimental diuretic effects of Rosmarinus officinalis and Centaurium erythraea
Rosmarinic acid specifically has also been studied for diuretic effects. One experiment found that it increased urine excretion and appeared to have a potassium-sparing capacity when combined with hydrochlorothiazide, a common pharmaceutical diuretic. When combined with amiloride (another diuretic), urine excretion still went up while sodium and potassium excretion went down.14PubMed. Involvement of Cholinergic and Cyclooxygenase Pathways in the Diuretic Effects of Rosmarinic Acid The potassium-sparing aspect is noteworthy because many conventional diuretics cause potassium depletion, which is a significant side effect for people who take them long-term.
For someone drinking rosemary tea regularly, the diuretic effect is probably very mild. But if you are taking prescription diuretics and adding concentrated rosemary supplements, there could be an additive effect worth discussing with your doctor.
Blood Pressure, ACE Inhibition, and Kidney Blood Flow
High blood pressure is the second leading cause of kidney failure, and anything that lowers blood pressure can indirectly benefit the kidneys. Rosemary has shown ACE-inhibitory activity in laboratory assays, meaning it can block the enzyme that constricts blood vessels and raises blood pressure. A review of herbal ACE inhibitors found that rosemary’s activity was comparable to pharmaceutical ACE inhibitors like captopril in lab settings.15PubMed. Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases
In a rat model of angiotensin II-induced hypertension, rosmarinic acid improved blood pressure and demonstrated antioxidant and vasodilatory effects.16PubMed Central. Rosmarinic acid improves hypertension and skeletal muscle glucose transport in angiotensin II-treated rats “Comparable to captopril in lab settings” does not mean comparable in your body, though. The dose, absorption, and duration of effect all differ enormously between a purified compound in a test tube and a pharmaceutical pill designed for predictable bioavailability. People on ACE inhibitors or other blood pressure medications should not swap them out for rosemary supplements based on preclinical comparisons.
What Happens to Rosmarinic Acid After You Swallow It
For any of these effects to matter in real life, rosemary’s active compounds have to survive digestion and reach the kidneys. Human pharmacokinetic data on rosmarinic acid exists, though it is limited. After oral intake via perilla extract (a rich source of rosmarinic acid), rosmarinic acid appeared in the blood within about 30 minutes, mostly as conjugated forms bound to glucuronic acid or sulfate. About 75% of the recovered metabolites were excreted in urine within the first six hours, and the total recovery in urine was roughly 6% of the ingested dose.17PubMed. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans
A separate study using pure rosmarinic acid in rats found a similar picture but with slower excretion. About 83% of the total metabolites showed up in urine between 8 and 18 hours after dosing. The majority of rosmarinic acid was broken down into caffeic acid, ferulic acid, and coumaric acid before being excreted.18Life Sciences. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid The fact that these metabolites pass through the kidneys means the organ does see rosmarinic acid and its breakdown products, but mostly in modified forms, not as the free compound used in many cell studies. Whether the conjugated forms retain the same protective activity is an open question, and it is one of the gaps that make the leap from lab dish to living human uncertain.
Rosemary Essential Oil and Diabetic Kidneys
Most of the research discussed so far involves rosemary extracts or isolated rosmarinic acid. Rosemary essential oil is a different preparation with a different chemical profile, heavier in terpenes like 1,8-cineole and camphor and lower in polyphenols. One study in diabetic rats found that rosemary essential oil supplementation improved kidney structure and showed antioxidant, anti-inflammatory, and anti-apoptotic effects. The combination of rosemary essential oil with insulin was more protective than either alone.19Cureus. Assessment of Effects of Rosemary Essential Oil on the Kidney Pathology of Diabetic Adult Male Albino Rats
This matters because consumers often do not distinguish between rosemary tea, rosemary extract capsules, and rosemary essential oil. These are not interchangeable. Essential oils are highly concentrated and are generally not meant to be ingested without professional guidance. The kidney-protective polyphenols (rosmarinic acid, carnosic acid) are more concentrated in water and alcohol extracts than in steam-distilled essential oil. If your interest is kidney health, a rosemary tea or a standardized extract is far closer to what the bulk of the research has actually tested.
Safety at High Doses
Rosemary at culinary levels is considered safe, and even concentrated preparations appear to have a wide margin. A 13-week toxicity study gave rats a rosemary concentrate (standardized to 50% ursolic acid) at doses up to 4,000 mg per kilogram of body weight per day. The researchers found no adverse effects on blood chemistry, organ weights, or kidney histology at any dose, and the no-observed-adverse-effect level exceeded the highest dose tested.20PubMed. A 13-week repeated oral dose toxicity evaluation and a 4-week recovery evaluation of rosemary concentrate containing 50% ursolic acid in male and female rats
There is one important exception. A study examining the effect of rosemary extract on the offspring of lactating rats found that a high dose of 1,000 mg per kilogram caused atrophic and degenerative changes in the liver and kidneys of the nursing pups, along with failure to gain weight. The researchers concluded that high-dose rosemary extract during lactation poses a risk and recommended that it be avoided during pregnancy and breastfeeding.21Iraqi Journal of Pharmacy. Effect of Rosemary Extract on Some Internal Organs of Young Male Albino Rats: A Histological Study The doses involved were far above what any reasonable supplement regimen would deliver, but the finding underscores that “natural” does not mean “harmless at any amount,” and that developing organisms are more vulnerable.
For the average adult using rosemary in cooking or taking a modest supplement, the existing safety data is reassuring. If you have existing kidney disease, are pregnant or nursing, or take medications metabolized through the kidneys or liver, consulting a healthcare provider before adding concentrated rosemary supplements makes sense. The mild diuretic and ACE-inhibitory properties could theoretically interact with blood pressure or fluid-balance medications.
The Gap Between Animal Studies and Your Kitchen
Reading through this research, you might wonder why, with so many positive animal findings, no one has done a proper human trial. Part of the answer is economic: rosemary cannot be patented, so the financial incentive to fund expensive clinical trials is low. Part of it is scientific: the doses used in animal studies, when scaled to human body weight, often translate to amounts that would be impractical to consume through food and that would require supplement-level dosing with all the regulatory and safety questions that entails.
There is also the bioavailability problem described earlier. Cell studies bathe kidney tissue directly in rosmarinic acid at concentrations that may not be achievable in a living human kidney after oral ingestion, digestion, liver metabolism, and conjugation. The compound that reaches your kidney cells is chemically different from the one dropped onto cells in a lab dish. This does not mean the effects vanish, but it means the effective dose in people could be quite different from what works in a petri dish.
What you can reasonably conclude is that rosemary is not harmful to healthy kidneys at normal dietary or moderate supplement levels, that its compounds have consistent protective effects in animal models of kidney damage, and that adding rosemary generously to your cooking is at worst neutral and at best mildly beneficial. Treating it as a medicine for diagnosed kidney disease, or using it as a substitute for prescribed treatment, is not supported by the current evidence. The preclinical story is compelling enough that clinical trials would be well justified, but until those trials exist, the honest answer is that rosemary looks good for kidneys in the lab and remains unproven in the clinic.